25 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
, cafeteria, medical, disability, death benefit, worker’s compensation, fringe
benefit, and each other employee benefit plan, policy, program, agreement … , severance, stamp, payroll, sales, employment, unemployment, disability, use, property, withholding, excise, production, value added, occupancy
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
: 65 (scores60 indicate “severe impact” and high disability) 34
STS101Mk2 demonstrates favorable safety and tolerability profile No clinically
424B5
STSA
Satsuma Pharmaceuticals Inc
3 Nov 22
Prospectus supplement for primary offering
4:42pm
most prevalent
S-4
illness, the sixth highest specific cause of disability worldwide, and the leading cause of disability in people under 50 years … of age. In addition, migraine is the second leading cause of disability worldwide in terms of number of years lost to disability. It has been estimated
S-3
gnekca9tma zvw
23 Oct 20
Shelf registration
4:48pm
10-K
4w1 owgddhd68
10 Mar 20
Annual report
4:20pm
424B4
egqaibxf
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
EX-10.5
yoidb06g8652t
3 Sep 19
IPO registration (amended)
6:12am
S-1/A
pcizune4m byz3nvj5g
3 Sep 19
IPO registration (amended)
6:12am
S-1
aocm4k2k
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.5
0xe g4hi6e
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.5
mx5j5oldd
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.4
m0d4kr muyd
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.9
ioxzj m62ecn2skrqf
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.7
wj21v2k771c3iim 45
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.8
yxhnabvs1 75k2s
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.4
dwd4ho 2w
16 Aug 19
IPO registration
5:15pm